Keyword: Keytruda

News

Keytruda Wins two new Cancer Approvals

12.06.2019 - Keytruda, the multi-indication oncology drug manufactured by US Merck & Co, has won approval from the Food and Drug Administration (FDA) for both monotherapy and combination...

News

Merck’s Keytruda Nabs More US Approvals

18.06.2018 - The US Food and Drug Administration (FDA) has granted two more approvals for US Merck’s Keytruda, an anti-PD-1 therapy. In the first, the drug gained its first regulatory clearance...

News

FDA Stops US Merck Keytruda Trials

12.07.2017 - The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...

News

US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...

News

UK Rejects Keytruda as First Lung Cancer Option

06.03.2017 - Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...

News

Merck Settles Keytruda Patent Disputes

24.01.2017 - US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

UK Health Agency Blesses Merck Cancer Drug

10.09.2015 - UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...